Efficacy of transvaginal erbium laser treatment for vaginal relaxation and its impact on vaginal microenvironment indicators
article
OA: bronze
CC0
Abstract
OBJECTIVE: To evaluate the efficacy of transvaginal erbium laser therapy in the treatment of Vaginal Relaxation Syndrome (VRS) and its effects on key indicators of vaginal health. METHODS: This retrospective study analyzed clinical data from women treated for VRS at the China-Japan Friendship Hospital. Participants were divided into two groups: laser therapy (n = 130) and estrogen treatment (n = 112). Demographic characteristics, clinical outcomes, vaginal microenvironment parameters, and sexual function were assessed. Primary outcomes included changes in pelvic floor muscle strength, vaginal atrophy scores, vaginal pH, lactobacilli grades, and sexual satisfaction. RESULTS: At the three-month follow-up, the laser group showed significant improvement in pelvic floor muscle strength (P = 0.046) and reductions in vaginal atrophy scores (P = 0.035) compared to the estrogen group. Additionally, patients in the laser group reported greater sexual satisfaction, including increased orgasm frequency (P = 0.007). While improvements in lactobacilli grades and vaginal pH were observed in the laser group, these changes were not statistically significant (both P > 0.05). Adverse reactions were mild and occurred less frequently in the erbium laser group (P < 0.05). CONCLUSION: Transvaginal erbium laser therapy is an effective intervention for alleviating VRS symptoms and enhancing pelvic floor muscle function. It also contributes to improved sexual satisfaction and supports the maintenance of a healthy vaginal microenvironment.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
References (37)
- doi:10.1097/dss.0000000000002845 via openalex
- doi:10.7573/dic.2020-3-7 via openalex
- doi:10.1080/009262301317081098 via openalex
- doi:10.1007/s00120-022-02012-1 via openalex
- doi:10.34172/jlms.2023.02 via openalex
- doi:10.1515/hmbci-2020-0012 via openalex
- doi:10.4103/gmit.gmit_141_20 via openalex
- doi:10.1038/s41598-025-85661-4 via openalex
- doi:10.1038/s41598-022-12007-9 via openalex
- doi:10.1080/13697137.2023.2225766 via openalex
- doi:10.1002/ijgo.15222 via openalex
- doi:10.1080/13697137.2020.1820478 via openalex
- doi:10.1007/s00192-020-04452-9 via openalex
- doi:10.1007/s10103-023-03798-y via openalex
- doi:10.3390/microorganisms8010130 via openalex
- doi:10.23736/s2724-606x.20.04612-2 via openalex
- doi:10.1080/1040841x.2022.2049696 via openalex
- doi:10.7759/cureus.55542 via openalex
- doi:10.3390/medicina58060770 via openalex
- doi:10.1097/gme.0000000000002326 via openalex
- doi:10.1007/s10103-021-03474-z via openalex
- doi:10.3109/01443615.2015.1014326 via openalex
- doi:10.1111/1471-0528.16558 via openalex
- doi:10.2147/ijwh.s414509 via openalex
- doi:10.1007/s10103-021-03305-1 via openalex
- doi:10.1186/s12905-023-02590-y via openalex
- doi:10.3389/fcimb.2021.792787 via openalex
- doi:10.1007/s00192-023-05635-w via openalex
- doi:10.1016/j.gofs.2021.03.021 via openalex
- doi:10.1097/gme.0000000000001673 via openalex
- doi:10.1186/s12934-022-01963-6 via openalex
- doi:10.3390/ijms25179168 via openalex
- doi:10.1016/j.jsxm.2021.12.010 via openalex
- doi:10.7759/cureus.62363 via openalex
- doi:10.1007/s10103-021-03484-x via openalex
- doi:10.3389/fcimb.2023.1153894 via openalex
- doi:10.7573/dic.2020-3-2 via openalex
Source provenance
- openalex
- last seen: 2026-05-14T06:25:39.257356+00:00
License: CC0
· commercial use OK